Rachel Rubin, MD
![](https://auau.auanet.org/sites/default/files/bio/13053987.Profile.png)
Dr. Rachel S. Rubin is a board certified urologist with fellowship training in sexual medicine for men and women. She did her urology training at Georgetown University and her fellowship in San Diego with Drs Irwin Goldstein and Eugene Rhee. She is an assistant clinical professor in urology at Georgetown University and clinical instructor at George Washington University.
Dr. Rubin is currently the education chair for the International Society for the Study of Women’s Sexual Health (ISSWSH) and an associate editor for the journal Sexual Medicine Reviews. She has fellowship designation from both ISSWSH and SMSNA and is the subsection editor of the female sexual medicine section of the AUA core curriculum.
Financial relationships
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Erectile Dysfunction)Ineligible company:Endo PharmaceuticalsDate added:Date updated:01/15/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Erectile Dysfunction)Ineligible company:absorption pharmaceuticalsDate added:Date updated:01/15/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)Ineligible company:sprout pharmaceuticalsDate added:Date updated:01/15/2023
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Non-urology Healthcare Related)Ineligible company:AbbvieDate added:Date updated:01/15/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Non-urology Healthcare Related)Ineligible company:FreyaDate added:Date updated:01/15/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Non-urology Healthcare Related)Ineligible company:AgileDate added:Date updated:01/15/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Non-urology Healthcare Related)Ineligible company:GSKDate added:Date updated:01/15/2023
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Female Pelvic Medicine & Reconstructive Surgery)Ineligible company:MaternaDate added:Date updated:01/15/2023